1. Home
  2. LRMR vs NRC Comparison

LRMR vs NRC Comparison

Compare LRMR & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LRMR
  • NRC
  • Stock Information
  • Founded
  • LRMR N/A
  • NRC 1981
  • Country
  • LRMR United States
  • NRC United States
  • Employees
  • LRMR N/A
  • NRC N/A
  • Industry
  • LRMR Biotechnology: Pharmaceutical Preparations
  • NRC Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • LRMR Health Care
  • NRC Health Care
  • Exchange
  • LRMR Nasdaq
  • NRC Nasdaq
  • Market Cap
  • LRMR 332.1M
  • NRC 278.8M
  • IPO Year
  • LRMR N/A
  • NRC N/A
  • Fundamental
  • Price
  • LRMR $3.45
  • NRC $14.35
  • Analyst Decision
  • LRMR Strong Buy
  • NRC
  • Analyst Count
  • LRMR 7
  • NRC 0
  • Target Price
  • LRMR $16.71
  • NRC N/A
  • AVG Volume (30 Days)
  • LRMR 1.8M
  • NRC 101.0K
  • Earning Date
  • LRMR 11-05-2025
  • NRC 10-27-2025
  • Dividend Yield
  • LRMR N/A
  • NRC 4.50%
  • EPS Growth
  • LRMR N/A
  • NRC N/A
  • EPS
  • LRMR N/A
  • NRC 0.71
  • Revenue
  • LRMR N/A
  • NRC $139,102,000.00
  • Revenue This Year
  • LRMR N/A
  • NRC N/A
  • Revenue Next Year
  • LRMR N/A
  • NRC N/A
  • P/E Ratio
  • LRMR N/A
  • NRC $19.71
  • Revenue Growth
  • LRMR N/A
  • NRC N/A
  • 52 Week Low
  • LRMR $1.61
  • NRC $9.76
  • 52 Week High
  • LRMR $9.50
  • NRC $21.64
  • Technical
  • Relative Strength Index (RSI)
  • LRMR 39.35
  • NRC 66.71
  • Support Level
  • LRMR $3.16
  • NRC $13.14
  • Resistance Level
  • LRMR $4.50
  • NRC $14.18
  • Average True Range (ATR)
  • LRMR 0.30
  • NRC 0.68
  • MACD
  • LRMR -0.10
  • NRC 0.35
  • Stochastic Oscillator
  • LRMR 24.09
  • NRC 100.00

About LRMR Larimar Therapeutics Inc.

Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.

About NRC National Research Corporation (Delaware)

National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.

Share on Social Networks: